29 July 2019 1 Min Read
Pfizer to merge unit with Mylan, sending Mylan shares soaring
Under new CEO Albert Bourla, Pfizer has been beefing up its cancer treatment pipeline, buying cancer drugmaker Array Biopharma in June
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In